He Ministry of Health began in January 2023 to gradually finance the continuous glucose monitoring devices For patients with type 2 diabetes insulin-dependent patients who require at least six blood glucose checks per day. In 2024, 1,419 type 2 diabetic patients will wear this sensor, or 67% more than in 2023 (which was 850). These systems measure blood sugar continuously.
The dthe devices are distributed free of chargefrom the health center to all patients, with a sufficient quantity for approximately two and a half months, since the sensor must be changed every 14 days.
THE financing of sensors For diabetic patients by the Ministry of Health began in 2020 for patients with type 1 diabetes. For people with type 2 diabetes, it began by first funding patients with visual impairment, functional limitations, disability, dependence or cognitive impairment that limits or prevents them from carrying out digital sampling. or recognize, express or act in a hypoglycemic situation; patients with a history of severe hypoglycemia, defined as those requiring health care or third-party help for resolution (1 or more episodes in the past 2 years); patients under 18 years old; and pregnant women or pregnant women.
This continued with patients suffering from unnoticed or repeated hypoglycemiaunderstood as those that occur at least 4 times per week or when 10% of the values of the glucometer readings are less than 70 mg/dl after having performed an average of 6 capillary blood glucose checks per day; patients who carry out risky professional activities and whose hypoglycemia may cause a dangerous situation for themselves or for third parties. Subsequently, patients suffering from concomitant processes of great complexity and clinical instability that could make hypoglycemia control difficult were funded. And later it spread to the rest of the patients.
6.7% of the Navarrese population is diabetic
November 14 is celebrated on World Diabetes Day. Currently, the number of living patients diagnosed with diabetes in Navarra is 45,464 (6.7% of the total population), of which 2,842 (6.2%) correspond to patients diagnosed with type 1 diabetes mellitus ( DM) and 42,622 (93.7%). Type 2 diabetes mellitus.
Monitoring of the patients diagnosed with type 1 diabetes It is carried out by the hospital endocrinology services, pediatric and adults, with a diabetes section included in the adult endocrinology service of the HUN and endocrinology consultations of the Reina Sofía de Tudela and García Orcoyen de Estella hospitals, with primary care support. Diabetes education for this group is provided by hospital care nursing staff.
Monitoring of the patients diagnosed with type 2 diabetes corresponds to Primary Care with the support of Hospital Care, in person and remotely, for specific problems or doubts, in protocolized cases generally associated with complications or complex treatments.
One in three patients admitted to HUN is diabetic
According to data from Endocrinology Department of the University Hospital of Navarrabetween 30 and 35% of people admitted to the center suffer from diabetes mellitus. Of these, approximately 5-10% are type 1 and the remainder are type 2, percentages similar to those recorded in other centers. The most common is that this condition is known at the time of admission, but, according to the Diabetes Section of the service, sometimes the person admitted was previously unaware that they were diabetic and the diagnosis occurs during their stay in hospital.
Due to this important percentage of diabetic patients hospitalizedIt is essential to homogenize treatments for adequate glycemic control during the duration of the patient’s hospitalization, because this good control will reduce the risk of complications linked to their disease and shorten the duration of hospitalization. It is for this reason that the Endocrinology Department maintains a protocol for “Management of hyperglycemia during hospitalization” which has just been updated according to the latest available data.
This protocol, accessible to all hospital professionals, includes the different treatment needs depending on the type of diabetes, adapted to the different clinical situations that a patient may go through, from emergency care to blood sugar management during surgery. or possible decompensations caused by medications or other reasons that may occur during admission.
Study for the Treatment and Prevention of Metabolic Syndrome
On the other hand, the Psychiatry Department of the University Hospital of Navarre has recently started, in collaboration with the Public University of Navarra, Navarrabiomed and the companies Genbioma Applications and MyVitale and the collaboration of the Rehabilitation Clinic and the First Episodes of Mental Health Psychosis Program, a pioneering study for treatment and prevention of the metabolic syndrome in patients with psychosis.
This syndrome, which causes diabetes and obesityis a frequent complication in these patients and can be three times higher than that observed in the general population, hence the interest in the development and evaluation of the effectiveness of new therapeutic alternatives with postbiotics which act on the microbiota and mitigate the associated metabolic risks.
This project benefits from funding from the Department of Industry and Ecological and Economic Digital Transition of the Government of Navarra and the European Regional Development Fund (ERDF) and will have a planned duration of two years.
